Related Experiment Videos
Allergic contact dermatitis from povidone-iodine: a re-evaluation study
1Department of Dermatology, Louvain University, 30 Clos Chapelle-aux-Champs, UCL 3033, B-1200 Brussels, Belgium. jean-marie.lachapelle@derm.ucl.ac.be
Contact Dermatitis
|February 11, 2005
Summary
Povidone-iodine (PVP-I) patch testing revealed a low rate of true allergic contact dermatitis (0.4%). Further investigation is crucial for allergens like PVP-I, which have both irritant and allergenic properties, to confirm clinical relevance.
Area of Science:
- Dermatology
- Allergology
- Contact Dermatitis
Background:
- Povidone-iodine (PVP-I) is a widely used antiseptic.
- Concerns exist regarding its potential to cause allergic contact dermatitis.
- Distinguishing true allergy from irritant reactions is clinically important.
Purpose of the Study:
- To determine the prevalence of true allergic contact dermatitis to PVP-I.
- To evaluate the diagnostic accuracy of patch testing for PVP-I allergy.
- To assess the clinical relevance of positive patch test reactions to PVP-I.
Main Methods:
- 500 consecutive patients underwent patch testing with a diluted PVP-I solution.
- Positive reactions were further assessed using a repeated open application test (ROAT).
- Patch test readings were performed at 2 and 4 days.
Main Results:
- 2.8% (14/500) of patients showed an initial positive patch test reaction to PVP-I.
- ROAT confirmed true allergy in only 2 of these 14 patients (0.4% of total).
- This indicates a significant number of false-positive patch test reactions.
Conclusions:
- True allergic contact dermatitis from PVP-I is uncommon (0.4%).
- PVP-I possesses both irritant and allergenic properties, necessitating careful interpretation of patch tests.
- Thorough investigation, including ROAT, is vital to confirm true allergy and clinical relevance for such dual-property allergens.